Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Deshan Madushanka"'
Autor:
Pradeep D. Pushpakumara, Chandima Jeewandara, Farha Bary, Deshan Madushanka, Lahiru Perera, Inoka Sepali Aberathna, Thashmi Nimasha, Jeewantha Jayamali, Thushali Ranasinghe, Heshan Kuruppu, Saubhagya Danasekara, Ananda Wijewickrama, Graham S. Ogg, Gathsaurie Neelika Malavige
BackgroundAs there are limited data on B cell epitopes for the nucleocapsid protein in SARS-CoV-2, we sought to identify the immunodominant regions within the N protein, recognized by patients with varying severity of natural infection with the Wuhan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfecc47eb086f0f4b7e3a3b7d2fcd09d
https://doi.org/10.1101/2023.01.05.23284247
https://doi.org/10.1101/2023.01.05.23284247
Autor:
Chandima Jeewandara, Tibutius T. P. Jayadas, Michael Harvie, Shashika Dayaratne, Banuri Gunasekera, Deshan Madushanka, Thushali Ranasinghe, Osanda Dissanayaka, Alain Townsend, Shyrar Tanussiya, Thashmi Nimasha, Gayasha Somathilaka, Madushika Dissanayaka, Ayesha Wijesinghe, Pradeep Pushpakumara, Ruwan Wijayamuni, Mpdj Jayamali, Lisa Schimanski, Pramila Rijal, Achala Kamaladasa, Anushika Mudunkotuwa, Heshan Kuruppu, Graham S. Ogg, Deshni Jayathilaka, Inoka Sepali Aberathna, Gathsaurie Neelika Malavige, Nayanathara Gamalath, Dinithi Ekanayaka, Tiong Kit Tan, Dinuka Guruge
IntroductionDue to limited access to vaccines, many countries have only administered a single dose of the AZD1222, while the dosage intervals have increased ≥ weeks. We sought to investigate the immunogenicity of a single dose of vaccine at ≥ 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf4ec9f2ed8d6777f013216d3314c084
https://doi.org/10.1101/2021.07.26.21261122
https://doi.org/10.1101/2021.07.26.21261122
Autor:
Graham S. Ogg, Dinithi Ekanayaka, Thushali Ranasinghe, Dinuka Guruge, Shashika Dayarathne, Saubhagya Danasekara, Nayanathara Gamalath, Alain Townsend, Achala Kamaladasa, Madushika Dissanayaka, Ayesha Wijesinghe, Shyrar Tanussiya, Tiong Kit Tan, Thashmi Nimasha, Tao Dong, Deshan Madushanka, Banuri Gunesekara, Anushika Mudunkotuwa, Mpdj Jayamali, Osanda Dissanayaka, Chandima Jeewandara, Tibutius T. P. Jayadas, Heshan Kuruppu, Inoka Sepali Aberathna, Gathsaurie Neelika Malavige, Gayasha Somathilaka, Deshni Jayathilaka, Michael Harvie, Ruwan Wijayamuni, Pradeep Pushpakumara, Lisa Schimanski
BackgroundAs there are limited data of the immunogenicity of the Sinopharm/BBIBP-CorV in different populations, antibody responses against different SARS-CoV-2 variants of concern and T cell responses, we investigated the immunogenicity of the vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95ad23a0c73b9af84584918e3585b530
https://doi.org/10.1101/2021.07.15.21260621
https://doi.org/10.1101/2021.07.15.21260621
Autor:
Vijith Gunasekara, Inoka Abeyratne, Laksiri Gomes, Deshan Madushanka, Heshan Kuruppu, Thilagaraj Pathmanathan, Ruwan Wijayamuni, Dinuka Guruge, Chandima Jeewandara, Tibutius T. P. Jayadas, Gathsaurie Neelika Malavige, Deshni Jayathilaka, Pradeep Pushpakumara, Graham S. Ogg, Saubhagya Danasekara, Gayasha Somathilaka, Indika Chathuranga
Publikováno v:
SSRN Electronic Journal.
Background SARS-CoV-2 rapid antigen (Ag) detection kits are widely used in addition to quantitative reverse transcription PCR PCR (RT-qPCR), as they are cheaper with a rapid turnaround time. As there are many concerns regarding their sensitivity and